Ingenix Raises €13m From Sofinnova Partners-Led Syndicate to Scale Modality Fusion, a Novel Architecture for Drug Development

Ingenix's Biological Reasoning Engine fuses biological data through Modality Fusion, a new architecture for AI in drug development. In a recent oncology engagement, the Biological Reasoning Engine accomplished in minutes what had taken the partner biotech several years and millions of...